LabCompass

April Rahrig

Medicine · Indiana University

OpenAlex ORCID
Hematopoietic Stem Cell TransplantationNeutropenia and Cancer InfectionsAcute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchCAR-T cell therapy research

Publications

39

Citations

123

Est. group size

—

Recurring co-author estimate

Active years

12

Publishing since 2015

Research summary
AI-generated

April Rahrig studies the care of children and young adults who receive hematopoietic stem cell transplants (bone marrow transplants) and CAR-T cell therapy, treatments used for leukemia and other blood cancers. Much of the work focuses on identifying, diagnosing, and managing the serious complications of these therapies, such as veno-occlusive disease, thrombotic microangiopathy, graft-versus-host disease, and lung and infection problems after transplant.

Pediatric hematopoietic stem cell transplantationTransplant complications (veno-occlusive disease, TMA, GVHD)CAR-T cell therapy and its side effectsPulmonary and infectious outcomes after transplantBlood cancers in children (leukemia)

Publication activity has grown notably over the last decade, rising from occasional papers to roughly 8-10 per year in 2024-2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 6.4/year recently
172018: 2 publications18192020: 3 publications202021: 1 publication212022: 3 publications222023: 7 publications232024: 8 publications242025: 10 publications10252026: 4 publications26
Recent publications
Publishes in
  • Transplantation and Cellular Therapy×5
  • Blood×4
  • Pediatric Blood & Cancer×3
  • Critical Care Medicine×3
  • Pediatric Transplantation×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile